| abstract |
The present invention provides a novel phenylcycloalkylmethylamine derivative for use in treating and / or preventing obesity and obesity-related comorbid signs and depression and depression-related comorbid signs. A compound represented by formula (I), or an isomer or pharmaceutically acceptable salt thereof. Wherein n is 1; SP is a C4 alkylene (butylene) spacer; X is O or S; R1 and R2 are each independently hydrogen, C1-6 alkoxy, or halogen; R3 is C1-6 alkyl; R4 is hydrogen; R5 is C1-6 alkyl) |